On July 16, 2024, SciSparc Ltd., a clinical-stage pharmaceutical company specializing in central nervous system disorders and rare diseases, announced that it received a Nasdaq Minimum Bid Price Notification. The notice from Nasdaq Stock Market LLC indicated that SciSparc is currently not meeting the minimum bid price requirement of $1.00 per share for continued listing, as stipulated by Nasdaq Listing Rule 5550(a)(2). However, the company has been granted a 180-day grace period to regain compliance, which extends until January 13, 2025. During this time, SciSparc's shares will continue to trade on Nasdaq under the symbol 'SPRC'. To regain compliance, the company's shares must close at $1.00 or higher for at least ten consecutive business days. If SciSparc fails to meet the requirement within...Show More

On July 16, 2024, SciSparc Ltd., a clinical-stage pharmaceutical company specializing in central nervous system disorders and rare diseases, announced that it received a Nasdaq Minimum Bid Price Notification. The notice from Nasdaq Stock Market LLC indicated that SciSparc is currently not meeting the minimum bid price requirement of $1.00 per share for continued listing, as stipulated by Nasdaq Listing Rule 5550(a)(2). However, the company has been granted a 180-day grace period to regain compliance, which extends until January 13, 2025. During this time, SciSparc's shares will continue to trade on Nasdaq under the symbol 'SPRC'. To regain compliance, the company's shares must close at $1.00 or higher for at least ten consecutive business days. If SciSparc fails to meet the requirement within the initial period, it may be eligible for an additional 180 days if it meets other initial listing standards, except for the minimum bid price. SciSparc is involved in drug development programs focusing on cannabinoid pharmaceuticals, including treatments for Tourette Syndrome, Alzheimer's disease, pain, ASD, and status epilepticus. The company also has a controlling interest in a subsidiary selling hemp seed oil-based products on Amazon.com.